Targeting HNRNPU to overcome cisplatin resistance in bladder cancer.
Mol Cancer. 2022 Feb 7;21(1):37. doi: 10.1186/s12943-022-01517-9.
Mol Cancer. 2022.
PMID: 35130920
Free PMC article.